Cardinal Health, Inc. (NYSE:CAH)

CAPS Rating: 4 out of 5

The Company is a provider of products and services that improve the safety and productivity of healthcare.

Results 1 - 20 of 70 : 1 2 3 4 Next »

Recs

0
Member Avatar jasar13 (< 20) Submitted: 3/19/2014 6:22:34 AM : Outperform Start Price: $73.03 CAH Score: -6.01

Strong Healthcare company with decent dividend set to profit from an aging population.

Recs

0
Member Avatar Heels10 (< 20) Submitted: 1/4/2014 12:40:49 PM : Outperform Start Price: $66.56 CAH Score: +0.77

Consistent dividend increases and capital opportunities from partnership with CVS/Caremark

Recs

0
Member Avatar afewgoodstocks11 (33.96) Submitted: 12/30/2013 11:33:33 AM : Outperform Start Price: $37.78 CAH Score: +42.99

Div. (Yield) $1.21 (1.8%)
Current Yield . . . . . . .3.18%

Recs

0
Member Avatar rossnr3 (69.97) Submitted: 6/4/2013 10:03:31 AM : Underperform Start Price: $46.13 CAH Score: -34.50

Industry trends counter to distributor model. Lost WAG and Express Scripts contracts.

Recs

0
Member Avatar 2trpop (94.13) Submitted: 6/18/2012 11:22:01 AM : Outperform Start Price: $40.36 CAH Score: +29.67

Long-Term Hold

Recs

0
Member Avatar mkklaren1968 (51.53) Submitted: 10/6/2011 12:18:37 AM : Outperform Start Price: $37.64 CAH Score: +18.02

Great P/E and P/S, 2% dividend yield. Strong company with a strong future ahead.

Recs

0
Member Avatar jahartmu (97.04) Submitted: 8/4/2011 11:13:05 AM : Outperform Start Price: $38.66 CAH Score: +25.12

Betting on an Ohio company that's also a leader in the medical industry. Cardinal should be well-positioned regardless of what happens to Washington's push for socialized medicine.

Recs

0
Member Avatar XMFConnor (97.85) Submitted: 6/6/2011 5:52:47 PM : Outperform Start Price: $41.24 CAH Score: +21.50

Einhorn Play

Recs

0
Member Avatar edremjo (52.93) Submitted: 7/19/2010 9:21:25 PM : Outperform Start Price: $31.87 CAH Score: +37.71

yes

Recs

0
Member Avatar dashark44 (95.90) Submitted: 7/16/2010 1:22:18 PM : Outperform Start Price: $32.27 CAH Score: +37.07

Dividend will keep this solid.

Recs

0
Member Avatar musclemilk13 (99.53) Submitted: 4/12/2010 3:36:05 PM : Outperform Start Price: $32.73 CAH Score: +52.50

4/12 screen #2: percentile and CS

speculating with new screen, high analyst opinion

Recs

0
Member Avatar havoc315 (96.90) Submitted: 4/12/2010 2:01:17 PM : Outperform Start Price: $32.70 CAH Score: +52.82

A winner from the health care reform

Recs

2
Member Avatar dnblack (71.77) Submitted: 3/5/2010 12:54:36 PM : Outperform Start Price: $32.09 CAH Score: +48.61

This is not a screaming deal but with the dividend factored in it looks like they should be priced between $42 and $50. EPS growth is around 3.5% for the past 8 years (with moderate variance), revenue growth is more consistent and around 9.5%.

Their net margin is low, debt is average, return on assets is high.

They compete directly with AmerisourceBergen and McKesson; all three seem to be quality companies with similar performance potential.

Recs

0
Member Avatar larryknows (51.03) Submitted: 3/4/2010 5:19:25 PM : Outperform Start Price: $32.05 CAH Score: +48.15

Recession proof niche.

Recs

0
Member Avatar nmartinov (< 20) Submitted: 1/30/2010 2:05:02 PM : Outperform Start Price: $30.05 CAH Score: +54.37

Long term buy

Recs

0
Member Avatar alars79 (56.72) Submitted: 1/21/2010 11:43:58 AM : Outperform Start Price: $28.87 CAH Score: +69.79

New filibuster-proof Congress should reduce the risk of any sweeping health care changes in the near future. Their focus on growing generics would help them remain competitive regardless. Solid ROE, good work being done to increase focus on core competancies, and pharmaceuticals should continue to have recession- and inflation-resistant demand.

Recs

0
Member Avatar ubber13 (< 20) Submitted: 11/29/2009 7:16:50 AM : Outperform Start Price: $28.94 CAH Score: +65.25

i have bought in at 27.90 and profited from this one.good company a benjamin graham pick. its currently at 12p/e and still a bargain.

Recs

0
Member Avatar spreadsheetV1 (99.14) Submitted: 11/23/2009 1:27:23 AM : Outperform Start Price: $29.05 CAH Score: +66.20

This met a high level screen to indicate a buy and strong outperform against its peers (other tickers in its industry). My 1st version of this spreadsheet devles deep into the company's balnace sheet and recent income statements, combined with other relevant price data for the company including insider/institutional holdings, short interest, debt levels, etc.
Testing capabilities of this 1st version of my automated, valuation spreadhseet matched with my personal criteria and see how it holds up.

Recs

0
Member Avatar trdavis33 (83.14) Submitted: 10/29/2009 2:37:57 PM : Outperform Start Price: $25.69 CAH Score: +90.41

They have made significant investments in themselves over the prior 10 years. They meant business and will weather the storm.

Recs

0
Member Avatar targetphil3 (< 20) Submitted: 10/23/2009 10:49:53 PM : Outperform Start Price: $25.92 CAH Score: +90.57

Current spinoff not such a bad thing. My mother has been with them 32+yrs, just had a little talk and she has decided to take a larger position in company. I believe they have been undervalued for some time and no matter what current administration does they will benefit due to "tentacles" they have had for some time. They are trading at about 50% discount to historical values, p/e and compared to others. Fundamentaly sound company that gets no respect!

Results 1 - 20 of 70 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement